Jesús
Corral Jaime
Ikertzailea 2022-(e)ra arte
Carolina BioOncology Institute
Huntersville, Estados UnidosCarolina BioOncology Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2020
-
Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study
Lung Cancer, Vol. 147, pp. 137-142